Presentation is loading. Please wait.

Presentation is loading. Please wait.

Fig. 3 Overall and disease-free survival of single-zone metastasis group according to the number of stations involved. No significant differences were.

Published byCamron Newton Modified over 6 years ago

Similar presentations

Presentation on theme: "Fig. 3 Overall and disease-free survival of single-zone metastasis group according to the number of stations involved. No significant differences were."— Presentation transcript:

1 Fig. 3 Overall and disease-free survival of single-zone metastasis group according to the number of stations involved. No significant differences were found in overall survival and disease-free survival according to the number of nodal stations involved (p = 0.80 and 0.38). Prognostic value of single nodal zone metastasis in non-small-cell lung cancer☆ Eur J Cardiothorac Surg. 2010;38(4): doi: /j.ejcts Eur J Cardiothorac Surg | © 2010 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.European Association for Cardio-Thoracic Surgery

2 Fig. 2 Overall and disease-free survival according to the number of nodal zones involved. The overall survival and disease-free survival were significantly better in the single-zone metastasis group than in 2-zone group (p = 0.003 and p ≪ 0.001) and there were no survival difference between two-zone and three-zone metastasis group (p = 0.75 and 0.45). Prognostic value of single nodal zone metastasis in non-small-cell lung cancer☆ Eur J Cardiothorac Surg. 2010;38(4): doi: /j.ejcts Eur J Cardiothorac Surg | © 2010 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.European Association for Cardio-Thoracic Surgery

3 Fig. 1 Overall and disease-free survival
Fig. 1 Overall and disease-free survival. The overall 5-year survival rate was 36.5% (median, 39.3 months). Median disease-free survival was 17.4 months. Prognostic value of single nodal zone metastasis in non-small-cell lung cancer☆ Eur J Cardiothorac Surg. 2010;38(4): doi: /j.ejcts Eur J Cardiothorac Surg | © 2010 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.European Association for Cardio-Thoracic Surgery

4 Table 3 Prevalence of nodal zones according to the primary tumor location of two-zone metastasis patients. Prognostic value of single nodal zone metastasis in non-small-cell lung cancer☆ Eur J Cardiothorac Surg. 2010;38(4): doi: /j.ejcts Eur J Cardiothorac Surg | © 2010 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.European Association for Cardio-Thoracic Surgery

5 Table 2 Prevalence of nodal zones according to the primary tumour location of single-zone metastasis patients. Prognostic value of single nodal zone metastasis in non-small-cell lung cancer☆ Eur J Cardiothorac Surg. 2010;38(4): doi: /j.ejcts Eur J Cardiothorac Surg | © 2010 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.European Association for Cardio-Thoracic Surgery

6 Table 1 Patient characteristics.
Prognostic value of single nodal zone metastasis in non-small-cell lung cancer☆ Eur J Cardiothorac Surg. 2010;38(4): doi: /j.ejcts Eur J Cardiothorac Surg | © 2010 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.European Association for Cardio-Thoracic Surgery

7 Table 4 Univariate analysis of prognostic factors for overall and disease-free survival.
Prognostic value of single nodal zone metastasis in non-small-cell lung cancer☆ Eur J Cardiothorac Surg. 2010;38(4): doi: /j.ejcts Eur J Cardiothorac Surg | © 2010 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.European Association for Cardio-Thoracic Surgery

8 Table 5 Multivariate analysis of prognostic factors for overall survival.
Prognostic value of single nodal zone metastasis in non-small-cell lung cancer☆ Eur J Cardiothorac Surg. 2010;38(4): doi: /j.ejcts Eur J Cardiothorac Surg | © 2010 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.European Association for Cardio-Thoracic Surgery

Download ppt "Fig. 3 Overall and disease-free survival of single-zone metastasis group according to the number of stations involved. No significant differences were."

Similar presentations

Fig.1 Complexity of the surgeries according to BAS. Histogram.

Fig.1 Complexity of the surgeries according to BAS. Histogram.
Fig. 1. TGF results in different group

Fig. 1. TGF results in different group
Table 1 Cause of death for arrested organ donors

Table 1 Cause of death for arrested organ donors
Table 1 Patient characteristics

Table 1 Patient characteristics
Fig. 1 Diagram of method C for bronchial closure

Fig. 1 Diagram of method C for bronchial closure
Vascular endothelial growth factor expression in non-small-cell lung cancer: Prognostic significance in squamous cell carcinoma  Hideyuki Imoto, MD, Toshihiro.

Vascular endothelial growth factor expression in non-small-cell lung cancer: Prognostic significance in squamous cell carcinoma  Hideyuki Imoto, MD, Toshihiro.
Fig. 1 Clinical model of coronary collateral flow

Fig. 1 Clinical model of coronary collateral flow
Table 1 Staging of resected tumours of the oesophagus

Table 1 Staging of resected tumours of the oesophagus
Table 1 Baseline characteristics of mitral valve operated patientsaaAF, atrial fibrillation; LA, left atrium; LVEDD, left ventricular end-diastolic.

Table 1 Baseline characteristics of mitral valve operated patientsaaAF, atrial fibrillation; LA, left atrium; LVEDD, left ventricular end-diastolic.
Table 2 Laboratory and echocardiographic values before LVAD implantation in the two groups. From: Reversibility of fixed pulmonary hypertension in left.

Table 2 Laboratory and echocardiographic values before LVAD implantation in the two groups. From: Reversibility of fixed pulmonary hypertension in left.
Table 1 Comparison of perioperative patient characteristics by groups

Table 1 Comparison of perioperative patient characteristics by groups
Fig. 1 Log-rank test comparing survival in patients undergoing surgical repair with those treated with TEVAR. Black line: TEVAR; grey line: surgical repair.

Fig. 1 Log-rank test comparing survival in patients undergoing surgical repair with those treated with TEVAR. Black line: TEVAR; grey line: surgical repair.
Prognosis of younger patients in non-small cell lung cancer

Prognosis of younger patients in non-small cell lung cancer
Table 1 Hospital mortality

Table 1 Hospital mortality
Figure 1: IPW-adjusted cumulative incidence function of cardiac death at 12 years, with non-cardiac death as competing risk. IPW: inverse probability of.

Figure 1: IPW-adjusted cumulative incidence function of cardiac death at 12 years, with non-cardiac death as competing risk. IPW: inverse probability of.
From: Long-term respiratory functional results after pneumonectomy

From: Long-term respiratory functional results after pneumonectomy
Table 2: Baseline characteristicsa of non-survivors and survivors and univariate logistic models predicting 30-day mortality From: The association.

Table 2: Baseline characteristicsa of non-survivors and survivors and univariate logistic models predicting 30-day mortality From: The association.
Fig. 1 Protocol for oral sildenafil administration for persistent postoperative pulmonary hypertension in paediatric patients. Each dose was given via.

Fig. 1 Protocol for oral sildenafil administration for persistent postoperative pulmonary hypertension in paediatric patients. Each dose was given via.
Table 1 Baseline patient characteristics

Table 1 Baseline patient characteristics
Table 1 Recipient’s characteristics.

Table 1 Recipient’s characteristics.

Similar presentations

Ads by Google